MARKET COMMENTARY

Too Early To Tell

Find out what your digital devices could be saying about your health. Helpful data for diagnosis and treatment, or privacy breach—that depends on us.

04.23.2020 - Fiduciary Trust Canada

In the world of poker, they’re known as tells—those physical and verbal moves a player makes, which give competitors valuable insights on their hand.[1] In day-to-day life, our tells also divulge a lot about our behaviour and that’s revealing a great deal more about our health.

With the aid of digital devices such as smartphones, wearables (e.g., fitness trackers), and smart speakers, we generate a rich trail of tells 24/7. For instance, the words we choose, the voice we use, how we sleep, how we play, where we go, how we tap the keyboard, all generate data central to a growing area of research. It’s called digital phenotyping and it’s helping solve one of the most significant missing pieces in medicine—the detailed understanding of ongoing patient behaviour. What we say in the doctor’s office, by error or omission, can leave out important clues for diagnosis and treatment today, and over time. Now, consider that in one study “scientists have analyzed how people use their phones to predict Parkinson’s disease with 100 percent accuracy.”[2]

Capturing massive amounts of passively produced user data is one thing, analyzing it and producing meaningful results is a whole other algorithm-based job. Right now, digital phenotyping can be divided into three main streams of research and business development: screening and diagnosing patients, symptom monitoring and interventions.[3]   

In keeping with the research, there’s a growing digital health care market, expected to reach $206 billion in 2021.[4] Emerging digital phenotyping companies will be active participants. For example, companies such as Mindstrong, Inc., have developed an app that’s meant to be a “smoke alarm” for people with mental health concerns. Monitoring over “1,000 smartphone related data points,” the app looks for changing mood and memory clues that often accompany depression.[5]

The potential opportunity for improving our health, for linking digital phenotyping with genetic research, for bridging the gap between behaviour and the growing trend of precision medicine—customizing treatments for each individual—is astounding.

Understandably, there’s also room for questions about individual privacy, data usage and data ownership. Where do the boundaries lie now and how will that look in the future? Building a framework for balancing the integrity of data usage with the possibilities for better health is important. How we choose to behave will tell the story in more ways than one.

 

 

1. Zachary Elwood and Giovanni Angioni, “Common Poker Tells: How to Read People in Poker,” PokerNews, December 4, 2019, https://www.pokernews.com.

2. Lois Parshley, “Our phones can now detect health problems from Parkinson’s to depression. Is that a good thing?” Vox, February 12, 2020, https://www.vox.com.

3. Lois Parshley, “Our phones can now detect health problems.”

4. Lois Parshley, “Our phones can now detect health problems.”

5. Natasha Singer, “How Companies Scour Our Digital Lives for Clues to Our Health,” The New York Times, February 25, 2018, https://www.nytimes.com.

MARKET COMMENTARY

Sticking To The Fundamentals

04.23.2020 Scott Guitard, Vice President, Portfolio Manager

From a top-down and bottom-up perspective, here’s a closer look at the fundamentals in action and why they’re important, always.

NEXT POST

MARKET COMMENTARY

Hearing The Unmistakable Roar

04.22.2020 Ian Riach, Chief Investment Officer

The word, unprecedented, sums up Q1—ranging from market volatility to fiscal and monetary initiatives worldwide. Here’s the quarter, in our view.

PREVIOUS POST